Tanzania: PM Urges Scientific Validation of Medicinal Plants

Tanzania's Prime Minister Dr Mwigulu Nchemba has called for accelerated scientific evaluation of the country's medicinal plants, emphasizing the potential for developing safe and certified remedies from its abundant natural resources. During the closing of the National Education, Skills and Innovation Week in Tanga, Nchemba stressed the need for stronger collaboration between health, education, and research sectors to ensure that traditional remedies undergo rigorous testing and certification.

Tanzania boasts a diverse range of plants that have traditionally been used for medicinal purposes, with scientific research now confirming their therapeutic value. The Prime Minister cited innovations from institutions like the Muhimbili University of Health and Allied Sciences (MUHAS), which showcased products believed to aid in treating prostate conditions.

He urged the Ministry of Education, Science and Technology to partner with the Ministry of Health and research institutions to subject such products to thorough scientific studies and obtain the necessary approvals before public availability.

Nchemba cautioned against the promotion of unverified medicines, warning that desperate patients may be misled by products whose safety and efficacy have not been proven. He emphasized the importance of following all research procedures and obtaining the required certification to ensure the safe use of these medicines. Additionally, he suggested a review of terminology used to describe medicines derived from medicinal plants, advocating for recognition as "medicines from Tanzania" if they have undergone laboratory processes, approvals, and scientific validation.

Regions such as Tanga, Tabora, and Singida, rich in medicinal plants, could serve as valuable raw materials for pharmaceutical research and production. Nchemba called for researchers, universities, and relevant institutions to collaborate in transforming traditional knowledge into scientifically validated medicines that meet national and international standards.

This would boost confidence in locally developed medicines, reduce reliance on unverified products, and create opportunities for Tanzania to manufacture and export pharmaceuticals derived from its natural resources.